Best practice guidance for the use of strategies to improve retention in randomized trials developed from two consensus workshops

Por Brueton, Valerie, Stenning, Sally P., Stevenson, Fiona, Tierney, Jayne, Rait, Greta
Publicado no J Clin Epidemiol (2017)

Assessing the potential for prevention or earlier detection of on-site monitoring findings from randomised controlled trials: Further analyses of findings from the prospective TEMP...

Por Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Publicado no Clin Trials (2020)

Dynamic methods for ongoing assessment of site-level risk in risk-based monitoring of clinical trials: A scoping review

Por Cragg, William J, Hurley, Caroline, Yorke-Edwards, Victoria, Stenning, Sally P
Publicado no Clin Trials (2021)

Implementing monitoring triggers and matching of triggered and control sites in the TEMPER study: a description and evaluation of a triggered monitoring management system

Por Diaz-Montana, Carlos, Cragg, William J., Choudhury, Rahela, Joffe, Nicola, Sydes, Matthew R., Stenning, Sally P.
Publicado no Trials (2019)

Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide an...

Por Cafferty, Fay H., White, Jeff D., Shamash, Jonathan, Hennig, Ivo, Stenning, Sally P., Huddart, Robert A.
Publicado no Eur J Cancer (2020)

Triggered or routine site monitoring visits for randomised controlled trials: results of TEMPER, a prospective, matched-pair study

Por Stenning, Sally P, Cragg, William J, Joffe, Nicola, Diaz-Montana, Carlos, Choudhury, Rahela, Sydes, Matthew R, Meredith, Sarah
Publicado no Clin Trials (2018)

Prognostic and predictive markers in recurrent high grade glioma; results from the BR12 randomised trial

Por Collins, Vincent Peter, Ichimura, Koichi, Di, Ying, Pearson, Danita, Chan, Ray, Thompson, Lindsay C, Gabe, Rhian, Brada, Michael, Stenning, Sally P
Publicado no Acta Neuropathol Commun (2014)

A Randomised Phase 2 Trial of Intensive Induction Chemotherapy (CBOP/BEP) and Standard BEP in Poor-prognosis Germ Cell Tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)

Por Huddart, Robert A., Gabe, Rhian, Cafferty, Fay H., Pollock, Philip, White, Jeff D., Shamash, Jonathan, Cullen, Michael H., Stenning, Sally P.
Publicado no Eur Urol (2015)

Defining a New Prognostic index for Stage I Non-seminomatous Germ Cell Tumors using CXCL12 Expression and Proportion of Embryonal Carcinoma

Por Gilbert, Duncan C, Al-Saadi, Reem, Thway, Khin, Chandler, Ian, Berney, Daniel, Gabe, Rhian, Stenning, Sally P, Sweet, Joan, Huddart, Robert, Shipley, Janet M
Publicado no Clin Cancer Res (2015)

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY1...

Por Mead, Graham M., Barrans, Sharon L., Qian, Wendi, Walewski, Jan, Radford, John A., Wolf, Max, Clawson, Simon M., Stenning, Sally P., Yule, Claire L., Jack, Andrew S.
Publicado em 2008

Biopsy proportion of tumour predicts pathological tumour response and benefit from chemotherapy in resectable oesophageal carcinoma: results from the UK MRC OE02 trial

Por Hale, Matthew D., Nankivell, Matthew, Hutchins, Gordon G., Stenning, Sally P., Langley, Ruth E., Mueller, Wolfram, West, Nicholas P., Wright, Alexander I., Treanor, Darren, Hewitt, Lindsay C., Allum, William H., Cunningham, David, Hayden, Jeremy D., Grabsch, Heike I.
Publicado no Oncotarget (2016)

Technical Reproducibility of Single-Nucleotide and Size-Based DNA Biomarker Assessment Using DNA Extracted from Formalin-Fixed, Paraffin-Embedded Tissues

Por Zhang, Shenli, Tan, Iain B., Sapari, Nur S., Grabsch, Heike I., Okines, Alicia, Smyth, Elizabeth C., Aoyama, Toru, Hewitt, Lindsay C., Inam, Imran, Bottomley, Dan, Nankivell, Matthew, Stenning, Sally P., Cunningham, David, Wotherspoon, Andrew, Tsuburaya, Akira, Yoshikawa, Takaki, Soong, Richie, Tan, Patrick
Publicado no J Mol Diagn (2015)

Peri-operative chemotherapy with or without bevacizumab in operable oesophagogastric adenocarcinoma (UK Medical Research Council ST03): primary analysis results of a multicentre, o...

Por Cunningham, David, Stenning, Sally P, Smyth, Elizabeth C, Okines, Alicia F, Allum, William H, Rowley, Sam, Stevenson, Laura, Grabsch, Heike I, Alderson, Derek, Crosby, Thomas, Griffin, S Michael, Mansoor, Wasat, Coxon, Fareeda Y, Falk, Stephen J, Darby, Suzanne, Sumpter, Kate A, Blazeby, Jane M, Langley, Ruth E
Publicado no Lancet Oncol (2017)

Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration

Por Olson, Thomas A., Murray, Matthew J., Rodriguez-Galindo, Carlos, Nicholson, James C., Billmire, Deborah F., Krailo, Mark D., Dang, Ha M., Amatruda, James F., Thornton, Claire M., Arul, G. Suren, Stoneham, Sara J., Pashankar, Farzana, Stark, Daniel, Shaikh, Furqan, Gershenson, David M., Covens, Allan, Hurteau, Jean, Stenning, Sally P., Feldman, Darren R., Grimison, Peter S., Huddart, Robert A., Sweeney, Christopher, Powles, Thomas, Lopes, Luiz Fernando, dos Santos Agular, Simone, Chinnaswamy, Girish, Khaleel, Sahar, Abouelnaga, Sherif, Hale, Juliet P., Frazier, A. Lindsay
Publicado no J Clin Oncol (2015)

Imaging Modality and Frequency in Surveillance of Stage I Seminoma Testicular Cancer: Results From a Randomized, Phase III, Noninferiority Trial (TRISST)

Por Joffe, Johnathan K., Cafferty, Fay H., Murphy, Laura, Rustin, Gordon J.S., Sohaib, Syed A., Gabe, Rhian, Stenning, Sally P., James, Elizabeth, Noor, Dipa, Wade, Simona, Schiavone, Francesca, Swift, Sarah, Dunwoodie, Elaine, Hall, Marcia, Sharma, Anand, Braybrooke, Jeremy, Shamash, Jonathan, Logue, John, Taylor, Henry H., Hennig, Ivo, White, Jeff, Rudman, Sarah, Worlding, Jane, Bloomfield, David, Faust, Guy, Glen, Hilary, Jones, Rachel, Seckl, Michael, MacDonald, Graham, Sreenivasan, Thiagarajan, Kumar, Satish, Protheroe, Andrew, Venkitaraman, Ramachandran, Mazhar, Danish, Coyle, Victoria, Highley, Martin, Geldart, Tom, Laing, Robert, Kaplan, Richard S., Huddart, Robert A.
Publicado no J Clin Oncol (2022)